Literature DB >> 33976409

Coronavirus variants are spreading in India - what scientists know so far.

Gayathri Vaidyanathan.   

Abstract

Entities:  

Keywords:  Epidemiology; Genomics; Infection; SARS-CoV-2; Virology

Year:  2021        PMID： 33976409     DOI： 10.1038/d41586-021-01274-7

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees.

Authors:  Pragya D Yadav; Gajanan N Sapkal; Priya Abraham; Raches Ella; Gururaj Deshpande; Deepak Y Patil; Dimpal A Nyayanit; Nivedita Gupta; Rima R Sahay; Anita M Shete; Samiran Panda; Balram Bhargava; V Krishna Mohan
Journal:  Clin Infect Dis       Date:  2022-01-29       Impact factor: 9.079
  1 in total
  56 in total

1.  Knowledge, perception, and fear among the global population towards newly evoked variant Omicron (B.1.1.529).

Authors:  Ali Qureshi; Syed Azhar Syed Sulaiman; Narendar Kumar; Pir Abdul Ahad Aziz Qureshi
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

2.  Fulminant onset COVID-19: predictors and outcome.

Authors:  Subrahmanian Sathiavageesan; Vivek Sundaram; Naveen Sundaram; Vimalraj Bogana Shanmugam; Joseph Selvaraj; Namrata Vivek; Gobinath Kanthasamy Ravi; Minu Velan; Chidambaram Palaniappan; Velvizhi Singaravelu; Manoj Prabhakar Shanmugam
Journal:  Postgrad Med J       Date:  2022-05-10       Impact factor: 4.973

3.  Vaccination and variants: Retrospective model for the evolution of Covid-19 in Italy.

Authors:  Annalisa Fierro; Silvio Romano; Antonella Liccardo
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

4.  Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks.

Authors:  Jacques Fantini; Nouara Yahi; Fodil Azzaz; Henri Chahinian
Journal:  J Infect       Date:  2021-06-03       Impact factor: 6.072

5.  COVID-19 associated mucormycosis (CAM) in India: a formidable challenge.

Authors:  Vishal U S Rao; Gururaj Arakeri; Gaurav Madikeri; Ashwin Shah; Rachel S Oeppen; Peter A Brennan
Journal:  Br J Oral Maxillofac Surg       Date:  2021-06-29       Impact factor: 2.018

Review 6.  Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids.

Authors:  Mari Numata; Dennis R Voelker
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2022-02-28       Impact factor: 5.228

7.  The surge in Covid related mucormycosis.

Authors:  Somesh Chandra; Rakesh Rawal
Journal:  J Infect       Date:  2021-06-12       Impact factor: 38.637

Review 8.  The emerging SARS-CoV-2 variants of concern.

Authors:  Adekunle Sanyaolu; Chuku Okorie; Aleksandra Marinkovic; Nafees Haider; Abu Fahad Abbasi; Urooj Jaferi; Stephanie Prakash; Vyshnavy Balendra
Journal:  Ther Adv Infect Dis       Date:  2021-06-18

Review 9.  Dynamically adjusted strategy in response to developments in the COVID-19 pandemic as a new normal.

Authors:  Weifeng Shen
Journal:  Global Health       Date:  2021-08-09       Impact factor: 4.185

10.  Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes.

Authors:  Dapeng Sun; Zhe Sang; Yong Joon Kim; Yufei Xiang; Tomer Cohen; Anna K Belford; Alexis Huet; James F Conway; Ji Sun; Derek J Taylor; Dina Schneidman-Duhovny; Cheng Zhang; Wei Huang; Yi Shi
Journal:  Nat Commun       Date:  2021-08-03       Impact factor: 17.694
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.